▶ 調査レポート

患者エンゲージメントソリューション(PES)の世界市場

• 英文タイトル:Global Market Study on Patient Engagement Solutions: Demand for Effective Patient Communication & Collaboration to Drive Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。患者エンゲージメントソリューション(PES)の世界市場 / Global Market Study on Patient Engagement Solutions: Demand for Effective Patient Communication & Collaboration to Drive Market Growth / MRC2110B010資料のイメージです。• レポートコード:MRC2110B010
• 出版社/出版日:Persistence Market Research / 2021年9月30日
• レポート形態:英文、PDF、382ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Individual User¥651,700 (USD4,900)▷ お問い合わせ
  Multi User¥1,010,800 (USD7,600)▷ お問い合わせ
  Corporate User¥1,409,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、患者エンゲージメントソリューション(PES)の世界市場について調査し、エグゼクティブサマリー、市場概要、市場に影響を与える主要動向、新型コロナウイルス感染症の影響分析、価格分析、市場構造分析、需要分析・予測、市場背景、ソリューション別(ソフトウェア、サービス)分析、展開別(クラウド、オンプレミス)分析、用途別(健康管理、社会的管理、在宅医療管理、財務健康管理、その他)分析、エンドユーザー別(忍耐患者、支払人、医療提供者、その他)分析、地域別分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・市場に影響を与える主要動向
・新型コロナウイルス感染症の影響分析
・価格分析
・市場構造分析
・需要分析・予測
・市場背景
・患者エンゲージメントソリューション(PES)の世界市場規模:ソリューション別(ソフトウェア、サービス)
・患者エンゲージメントソリューション(PES)の世界市場規模:展開別(クラウド、オンプレミス)
・患者エンゲージメントソリューション(PES)の世界市場規模:用途別(健康管理、社会的管理、在宅医療管理、財務健康管理、その他)
・患者エンゲージメントソリューション(PES)の世界市場規模:エンドユーザー別(忍耐患者、支払人、医療提供者、その他)
・患者エンゲージメントソリューション(PES)の世界市場規模:地域別
・競争分析
・仮定
・調査手法

Patient Engagement Solution Market – Report Scope

The research study on the patient engagement solution market offers a close look at evolving aspects of the market, as well as the dynamics impacting market growth. The research study focuses on key developments that have made their mark in the patient engagement solution market, and other developments that are on the cards. The report talks about various macro- and micro-economic factors responsible for having an in-depth impact on the growth of the market over the forecast period of 2021 to 2031.

A direct market overview provides the growth scenario and market potential with maximum precision, which is adjudged with suitable assumptions. The report features unique and relevant factors that are likely to have a significant impact on the sales of patient engagement solutions during the forecast period. This report includes a detailed and considerable amount of information, which will help new manufacturers and service providers in the most comprehensive manner for better understanding.

Several stakeholders in the market can rely on the data offered in this research study, and delve into pragmatic decision-making. Moreover, information offered in the report also helps new market entrants in expanding their bases in this space.

The report elaborates historical and current trends molding the growth of the patient engagement solution market. The performance journey of the market has been drawn and analyzed in way that the lucrative side is evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.

Market Segmentation

Persistence Market Research’s study on the global patient engagement solution market offers a detailed market segmentation, wherein, key segments have been discussed in detail. The segmentation of the market has been offered on the basis of solution, deployment, application, end user, and region. Every segment has been analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

[Solution]
Solution
Integrated Patient Engagement Software
Standalone Software
Scheduling Software
Billing Software
Secure Messaging Software
Others
Services
Implementation & Integration
Consulting
Support & Maintenance

[Deployment]
Cloud
On-Premise

[Application]
Health Management
Social Management
Home Healthcare Management
Financial Health Management
Others

[End User]
Patients
Payers
Healthcare Providers
Others

[Region]
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Taxonomy

2.2. Market Definition

3. Key Trends Impacting the Market

3.1. Easy and Efficient Access to Patient Engagement Tools and Solutions

3.2. Initiatives for Development of Healthcare Sector from Government

3.3. Other trends

4. COVID-19 Impact Analysis

4.1. Impact of COVID-19 on Patient Engagement Solution Market

4.1.1. Pre COVID-19 Market Growth

4.1.2. Post COVID-19 Market Growth

4.2. Expected Market Recovery Scenario (Short Term/Long Term)

4.3. Key Strategies/Action Points

5. Pricing Analysis

5.1. Pricing Analysis, By Solution

5.2. Average Pricing Benchmark Analysis

6. Market Structure Analysis

6.1. Market Share Analysis, By Key Vendors (Global-level)

6.2. Market Presence Analysis, By Regional Footprint

6.3. Market Positioning by Tier of Vendors (Tier 1/2/3)

7. Global Patient Engagement Solution Market Demand (in Value or Size in US$ Mn) Analysis 2016–2020 and Forecast, 2021–2031

7.1. Historical Market Value (US$ Mn) Analysis, 2016–2020

7.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Market Background

8.1. Macro-Economic Factors

8.2. Forecast Factors – Relevance & Impact

8.3. Value Chain

8.4. Market Dynamics

8.4.1. Drivers

8.4.2. Restraints

8.4.3. Opportunity Analysis

9. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Solution

9.1. Introduction / Key Findings

9.2. Historical Market Value (US$ Mn Analysis By Solution, 2016–2020

9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Solution, 2021–2031

9.3.1. Software

9.3.1.1. Integrated Patient Engagement Software

9.3.1.2. Standalone Software

9.3.1.2.1. Scheduling Software

9.3.1.2.2. Billing Software

9.3.1.2.3. Secure Messaging Software

9.3.1.2.4. Others

9.3.2. Services

9.3.2.1. Implementation & Integration

9.3.2.2. Consulting

9.3.2.3. Support & Maintenance

9.4. Market Attractiveness Analysis By Solution

10. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Deployment

10.1. Introduction / Key Findings

10.2. Historical Market Value (US$ Mn) Analysis By Deployment, 2016–2020

10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Deployment, 2021–2031

10.3.1. Cloud-based

10.3.2. On-premise

10.4. Market Attractiveness Analysis By Deployment

11. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Application

11.1. Introduction / Key Findings

11.2. Historical Market Value (US$ Mn) Analysis By Application, 2016–2020

11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2021–2031

11.3.1. Health Management

11.3.2. Social Management

11.3.3. Home Healthcare Management

11.3.4. Financial Health Management

11.3.5. Others

11.4. Market Attractiveness Analysis By Application

12. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by End user

12.1. Introduction / Key Findings

12.2. Historical Market Value (US$ Mn) Analysis By End user, 2016–2020

12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End user, 2021–2031

12.3.1. Patients

12.3.2. Payers

12.3.3. Healthcare Providers

12.3.4. Others

12.4. Market Attractiveness Analysis By End user

13. Global Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031, by Region

13.1. Introduction

13.2. Historical Market Value (US$ Mn) Analysis By Region, 2016–2020

13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021–2031

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. South Asia and Pacific

13.3.5. East Asia

13.3.6. Middle East and Africa

13.4. Market Attractiveness Analysis By Region

14. North America Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Solution

14.3.3. By Deployment

14.3.4. By Application

14.3.5. By End user

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Solution

14.4.3. By Deployment

14.4.4. By Application

14.4.5. By End user

14.5. Drivers and Restraints: Impact Analysis

15. Latin America Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Solution

15.3.3. By Deployment

15.3.4. By Application

15.3.5. By End user

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Solution

15.4.3. By Deployment

15.4.4. By Application

15.4.5. By End user

15.5. Drivers and Restraints: Impact Analysis

16. Europe Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. U.K.

16.3.1.5. Spain

16.3.1.6. BENELUX

16.3.1.7. Russia

16.3.1.8. Rest of Europe

16.3.2. By Solution

16.3.3. By Deployment

16.3.4. By Application

16.3.5. By End user

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Solution

16.4.3. By Deployment

16.4.4. By Application

16.4.5. By End user

16.5. Drivers and Restraints: Impact Analysis

17. South Asia and Pacific Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

17.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

17.3.1. By Country

17.3.1.1. India

17.3.1.2. ASEAN

17.3.1.3. Australia and New Zealand

17.3.1.4. Rest of South Asia and Pacific

17.3.2. By Solution

17.3.3. By Deployment

17.3.4. By Application

17.3.5. By End user

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Solution

17.4.3. By Deployment

17.4.4. By Application

17.4.5. By End user

17.5. Drivers and Restraints: Impact Analysis

18. East Asia Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

18.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

18.3.1. By Country

18.3.1.1. China

18.3.1.2. Japan

18.3.1.3. South Korea

18.3.2. By Solution

18.3.3. By Deployment

18.3.4. By Application

18.3.5. By End user

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Solution

18.4.3. By Deployment

18.4.4. By Application

18.4.5. By End user

18.5. Drivers and Restraints: Impact Analysis

19. Middle East and Africa Patient Engagement Solution Market Analysis 2016–2020 and Forecast 2021–2031

19.1. Introduction

19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020

19.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. Turkey

19.3.1.3. South Africa

19.3.1.4. Rest of Middle East and Africa

19.3.2. By Solution

19.3.3. By Deployment

19.3.4. By Application

19.3.5. By End user

19.4. Market Attractiveness Analysis

19.4.1. By Country

19.4.2. By Solution

19.4.3. By Deployment

19.4.4. By Application

19.4.5. By End user

19.5. Drivers and Restraints: Impact Analysis

20. Key and Emerging Countries Patient Engagement Solution Market Analysis

20.1. U.S. Patient Engagement Solution Market Opportunity Analysis

20.1.1. By Solution

20.1.2. By Deployment

20.1.3. By Application

20.1.4. By End user

20.2. Canada Patient Engagement Solution Market Opportunity Analysis

20.2.1. By Solution

20.2.2. By Deployment

20.2.3. By Application

20.2.4. By End user

20.3. Mexico Patient Engagement Solution Market Opportunity Analysis

20.3.1. By Solution

20.3.2. By Deployment

20.3.3. By Application

20.3.4. By End user

20.4. Brazil Patient Engagement Solution Market Opportunity Analysis

20.4.1. By Solution

20.4.2. By Deployment

20.4.3. By Application

20.4.4. By End user

20.5. Germany Patient Engagement Solution Market Opportunity Analysis

20.5.1. By Solution

20.5.2. By Deployment

20.5.3. By Application

20.5.4. By End user

20.6. Italy Patient Engagement Solution Market Opportunity Analysis

20.6.1. By Solution

20.6.2. By Deployment

20.6.3. By Application

20.6.4. By End user

20.7. France Patient Engagement Solution Market Opportunity Analysis

20.7.1. By Solution

20.7.2. By Deployment

20.7.3. By Application

20.7.4. By End user

20.8. U.K. Patient Engagement Solution Market Opportunity Analysis

20.8.1. By Solution

20.8.2. By Deployment

20.8.3. By Application

20.8.4. By End user

20.9. Spain Patient Engagement Solution Market Opportunity Analysis

20.9.1. By Solution

20.9.2. By Deployment

20.9.3. By Application

20.9.4. By End user

20.10. BENELUX Patient Engagement Solution Market Opportunity Analysis

20.10.1. By Solution

20.10.2. By Deployment

20.10.3. By Application

20.10.4. By End user

20.11. Russia Patient Engagement Solution Market Opportunity Analysis

20.11.1. By Solution

20.11.2. By Deployment

20.11.3. By Application

20.11.4. By End user

20.12. China Patient Engagement Solution Market Opportunity Analysis

20.12.1. By Solution

20.12.2. By Deployment

20.12.3. By Application

20.12.4. By End user

20.13. Japan Patient Engagement Solution Market Opportunity Analysis

20.13.1. By Solution

20.13.2. By Deployment

20.13.3. By Application

20.13.4. By End user

20.14. S. Korea Patient Engagement Solution Market Opportunity Analysis

20.14.1. By Solution

20.14.2. By Deployment

20.14.3. By Application

20.14.4. By End user

20.15. India Patient Engagement Solution Market Opportunity Analysis

20.15.1. By Solution

20.15.2. By Deployment

20.15.3. By Application

20.15.4. By End user

20.16. ASEAN Patient Engagement Solution Market Opportunity Analysis

20.16.1. By Solution

20.16.2. By Deployment

20.16.3. By Application

20.16.4. By End user

20.17. Australia and New Zealand Patient Engagement Solution Market Opportunity Analysis

20.17.1. By Solution

20.17.2. By Deployment

20.17.3. By Application

20.17.4. By End user

20.18. GCC Countries Patient Engagement Solution Market Opportunity Analysis

20.18.1. By Solution

20.18.2. By Deployment

20.18.3. By Application

20.18.4. By End user

20.19. Turkey Patient Engagement Solution Market Opportunity Analysis

20.19.1. By Solution

20.19.2. By Deployment

20.19.3. By Application

20.19.4. By End user

20.20. South Africa Patient Engagement Solution Market Opportunity Analysis

20.20.1. By Solution

20.20.2. By Deployment

20.20.3. By Application

20.20.4. By End user

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Deep Dive

21.2.1. Allscripts Healthcare Solutions

21.2.1.1. Business Overview

21.2.1.2. Solution Offering

21.2.1.3. Financial Performance

21.2.1.4. Key Strategies

21.2.2. McKesson Corporation

21.2.2.1. Business Overview

21.2.2.2. Solution Offering

21.2.2.3. Financial Performance

21.2.2.4. Key Strategies

21.2.3. Cerner Corporation

21.2.3.1. Business Overview

21.2.3.2. Solution Offering

21.2.3.3. Financial Performance

21.2.3.4. Key Strategies

21.2.4. Phytel Inc

21.2.4.1. Business Overview

21.2.4.2. Solution Offering

21.2.4.3. Financial Performance

21.2.4.4. Key Strategies

21.2.5. Medecision Inc

21.2.5.1. Business Overview

21.2.5.2. Solution Offering

21.2.5.3. Financial Performance

21.2.5.4. Key Strategies

21.2.6. Athenahealth, Inc.

21.2.6.1. Business Overview

21.2.6.2. Solution Offering

21.2.6.3. Financial Performance

21.2.6.4. Key Strategies

21.2.7. Novartis

21.2.7.1. Business Overview

21.2.7.2. Solution Offering

21.2.7.3. Financial Performance

21.2.7.4. Key Strategies

21.2.8. Roche Holding AG

21.2.8.1. Business Overview

21.2.8.2. Solution Offering

21.2.8.3. Financial Performance

21.2.8.4. Key Strategies

21.2.9. Bayer

21.2.9.1. Business Overview

21.2.9.2. Solution Offering

21.2.9.3. Financial Performance

21.2.9.4. Key Strategies

21.2.10. GlaxoSmithKline

21.2.10.1. Business Overview

21.2.10.2. Solution Offering

21.2.10.3. Financial Performance

21.2.10.4. Key Strategies

21.2.11. IQVIA

21.2.11.1. Business Overview

21.2.11.2. Solution Offering

21.2.11.3. Financial Performance

21.2.11.4. Key Strategies

22. Assumptions and Acronyms Used

23. Research Methodology